Copyright
©The Author(s) 2022.
World J Gastroenterol. Sep 14, 2022; 28(34): 4943-4958
Published online Sep 14, 2022. doi: 10.3748/wjg.v28.i34.4943
Published online Sep 14, 2022. doi: 10.3748/wjg.v28.i34.4943
Table 3 Characteristics of the subtypes of neuroendocrine neoplasms of the stomach
Characteristics | Type I | Type II | Type III |
Prevalence | 70%-80% | 5%-10% | 10%-20% |
Background | Autoimmune chronic atrophic gastritis | Gastrinomas (Zollinger-Ellison syndrome) | Normal mucosa |
Number of lesions | Multiple | Multiple | Single |
Size of tumors | 1-2 cm | 1 cm | > 2 cm |
Site of tumor | Corpus and/or fundus | Corpus and/or fundus | Anywhere |
Serum gastrin levels | Elevated | Elevated | Normal |
Gastric pH | High | Low | Normal |
Invasion | Rare | More common | Common |
Prognosis (5-yr survival) | Excellent (90%-95%) | Good (70%-90%) | Worse (less than 35%) |
- Citation: Iabichino G, Di Leo M, Arena M, Rubis Passoni GG, Morandi E, Turpini F, Viaggi P, Luigiano C, De Luca L. Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(34): 4943-4958
- URL: https://www.wjgnet.com/1007-9327/full/v28/i34/4943.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i34.4943